Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME） [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial to evaluate the efficacy and safety of IBI302 in subjects with diabetic macular edema. The study status is Recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• IBI302

Snippet

Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) | Conditions: Diabetic Macular Oedema | Phase 2 | Status: RECRUITING